We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RXN market cap is 11.22B. The company's latest EPS is USD 0.6522 and P/E is 49.79.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 372.1M | 403.2M | 398.4M | 356.8M | 373.8M |
| Operating Income | 43.7M | 54.8M | 60.1M | 32.8M | 53.2M |
| Net Income | 22.8M | 34.6M | 41.4M | 13.9M | 34.3M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.07B | 1.43B | 910.9M | 1.28B | 1.53B |
| Operating Income | 334.3M | 188.4M | 107M | 107.1M | 191.4M |
| Net Income | 165.7M | 118.2M | 120.9M | 61.7M | 112.7M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.81B | 2.8B | 2.81B | 2.67B | 2.66B |
| Total Liabilities | 1.21B | 1.21B | 1.2B | 1.06B | 1.05B |
| Total Equity | 1.6B | 1.59B | 1.61B | 1.6B | 1.61B |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.63B | 3.4B | 1.08B | 2.86B | 2.67B |
| Total Liabilities | 2.31B | 1.96B | 951.3M | 1.25B | 1.06B |
| Total Equity | 1.31B | 1.44B | 126.4M | 1.62B | 1.6B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.4M | 92.2M | 195.7M | 253.9M | 53.9M |
| Investing | -5.2M | -1.8M | -6.6M | -4.6M | -2.1M |
| Financing | -50.3M | -113.5M | -141.5M | -239.2M | -30.9M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 298.6M | 196.3M | 223.6M | 97M | 253.9M |
| Investing | -123.1M | -122.5M | -21.9M | -6.6M | -4.6M |
| Financing | 114.9M | -409.6M | -356.2M | -61.1M | -239.2M |
| Market Cap | 11.22B |
| Price to Earnings Ratio | 49.79 |
| Price to Sales Ratio | 3.67 |
| Price to Cash Ratio | 41.05 |
| Price to Book Ratio | 3.5 |
| Dividend Yield | - |
| Shares Outstanding | 172.81M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.7 (4.19%) |
| Company Name | Rexnord Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.zurn-elkay.com |
| Industry | general industrial mach & eq (3560) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
